Vertex Pharmaceuticals Ownership | Who Owns Vertex Pharmaceuticals?


OverviewForecastRevenueFinancialsChartTranscripts

Vertex Pharmaceuticals Ownership Summary


Vertex Pharmaceuticals is owned by 17.34% institutional investors, 0.18% insiders, and 82.48% retail investors. Capital world investors is the largest institutional shareholder, holding 9.92% of VRTX shares. Capital Group Growth Fnd of Amer Comp is the top mutual fund, with 5.48% of its assets in Vertex Pharmaceuticals shares.

VRTX Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockVertex Pharmaceuticals17.34%0.18%82.48%
SectorHealthcare Stocks 232.86%10.65%-143.51%
IndustryBiotech Stocks 382.13%10.41%-292.54%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Capital world investors25.37M9.92%$11.33B
Vanguard group24.11M9.43%$10.93B
Blackrock funding, inc. /de23.97M9.37%$10.70B
Capital research global investors21.13M8.26%$9.43B
Blackrock21.31M8.25%$9.99B
State street11.61M4.52%$4.55B
Jpmorgan chase7.03M2.75%$3.12B
Geode capital management5.98M2.34%$2.70B
Capital investors5.13M2.00%$2.29B
Wellington management group llp4.77M1.86%$1.87B

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Kynam capital management, lp330.00K11.93%$154.68M
Provident investment management147.62K6.55%$65.92M
Andrew hill investment advisors11.96K4.76%$5.34M
Montchanin asset management10.74K4.76%$5.03M
Bellevue group505.81K4.12%$198.09M
Bridger management18.78K3.96%$7.35M
Healthinvest partners ab22.98K3.61%$11.17M
Artia global partners lp55.10K3.42%$21.58M
Sivik global healthcare10.00K3.39%$4.46M
Mcrae capital management35.56K3.29%$16.12M

Top Buyers

HolderShares% AssetsChange
Capital research global investors21.13M1.46%3.81M
Norges bank3.18M0.15%3.18M
Vanguard fiduciary trust1.47M0.17%1.47M
Jpmorgan chase7.03M0.20%993.67K
Winslow capital management887.64K1.36%887.64K

Top Sellers

HolderShares% AssetsChange
Fmr3.30M0.07%-3.10M
Parnassus investments---1.65M
Artisan partners limited partnership---650.26K
Blackrock21.31M0.23%-648.44K
Jennison associates2.74M0.84%-509.48K

New Positions

HolderShares% AssetsChangeValue
Norges bank3.18M0.15%3.18M$1.44B
Vanguard fiduciary trust1.47M0.17%1.47M$654.50M
Winslow capital management887.64K1.36%887.64K$405.10M
Vanguard global advisers555.73K0.13%555.73K$248.16M
Vanguard asset management442.18K0.17%442.18K$197.45M

Sold Out

HolderChange
Mcclarren financial advisors-1.00
Cgc financial services-1.00
Ruedi wealth management-1.00
Mine & arao wealth creation & management, llc.-1.00
Perkins coie trust-1.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 2025806-48.63%44,328,589-80.90%170.21%410-40.58%269-56.19%
Sep 30, 2025865-46.24%59,581,660-75.23%230.26%362-50.82%356-41.54%
Jun 30, 20251,575-5.06%240,147,0121.70%931.11%716-14.86%5994.90%
Mar 31, 20251,6401.74%235,693,425-0.06%911.09%82911.42%567-7.35%
Dec 31, 20241,444-9.69%218,148,736-5.74%841.05%664-9.78%543-5.89%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Capital Group Growth Fnd of Amer Comp13.93M5.48%950.21K
American Funds Growth Fund of Amer A13.93M5.48%950.21K
Vanguard US Total Market Shares ETF8.18M3.19%16.09K
Vanguard Total Stock Mkt Idx Inv8.07M3.17%48.91K
Vanguard Institutional 500 Index Trust7.30M2.84%51.91K
Vanguard 500 Index Investor6.47M2.54%-57.29K
Capital Group Investment Co of Amer Comp6.27M2.46%832.14K
American Funds Invmt Co of Amer A6.27M2.46%832.14K
American Funds American Balanced A5.93M2.33%1.31M
Invesco QQQ Trust5.44M2.14%39.96K

Recent Insider Transactions


DateNameRoleActivityValue
May 01, 2026Liu Joy EVP and Chief Legal OfficerSell$469.22K
May 04, 2026Bhatia Sangeeta N.-Sell$134.75K
Apr 01, 2026Liu Joy EVP and Chief Legal OfficerSell$439.29K
Mar 27, 2026Bozic Carmen EVP and CMOSell$1.05M
Mar 13, 2026Bozic Carmen EVP and CMOSell$1.12M

Insider Transactions Trends


DateBuySell
2026 Q2-3
2026 Q1-56
2025 Q4-23
2025 Q341
2025 Q2-2

VRTX Ownership FAQ


Who Owns Vertex Pharmaceuticals?

Vertex Pharmaceuticals shareholders are primarily institutional investors at 17.34%, followed by 0.18% insiders and 82.48% retail investors. The average institutional ownership in Vertex Pharmaceuticals's industry, Biotech Stocks , is 382.13%, which Vertex Pharmaceuticals falls below.

Who owns the most shares of Vertex Pharmaceuticals?

Vertex Pharmaceuticals’s largest shareholders are Capital world investors (25.37M shares, 9.92%), Vanguard group (24.11M shares, 9.43%), and Blackrock funding, inc. /de (23.97M shares, 9.37%). Together, they hold 28.73% of Vertex Pharmaceuticals’s total shares outstanding.

Does Blackrock own Vertex Pharmaceuticals?

Yes, BlackRock owns 8.25% of Vertex Pharmaceuticals, totaling 21.31M shares as of Jun 2024. This represents 0.23% of BlackRock's total assets, with a market value of 9.99B$. In the last quarter, BlackRock decreased its holdings by -648K shares, a -2.95% change.

Who is Vertex Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Kynam capital management, lp is Vertex Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 11.93% of its assets in 330K Vertex Pharmaceuticals shares, valued at 154.68M$.

Who is the top mutual fund holder of Vertex Pharmaceuticals shares?

Capital Group Growth Fnd of Amer Comp is the top mutual fund holder of Vertex Pharmaceuticals shares, with 5.48% of its total shares outstanding invested in 13.93M Vertex Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools